PMID:37801550 | DOI:10.1177/10781552231205779
PubMed articles on: Cancer & VTE/PE
Thromb Res. 2023 Oct 4;231:50-57. doi: 10.1016/j.thromres.2023.10.005. Online ahead of print.
ABSTRACT Doxorubicin (Dox) is a highly potent chemotherapy drug. Despite its efficacy, Dox's clinical application is limited due to it...
No comments:
Post a Comment
اكتب تعليق حول الموضوع